UTMD
Utah Medical Products Inc
74.50$
+0.9%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 41.0% | 43.2% | 46.5% | 26.6% | 38.5% | 32.1% | 46.0% | 28.9% | 39.5% | 38.4% | 35.6% | 16.2% | 32.8% | |
| 14.3% | 8.4% | 6.0% | 6.7% | 7.4% | 8.0% | 7.4% | 7.6% | 7.8% | 8.4% | 7.9% | 2.8% | 6.8% | |
| 0.4% | 0.6% | 0.7% | 0.5% | 0.5% | 0.8% | 0.8% | 0.9% | 1.0% | 1.2% | 1.4% | 0.8% | 1.1% | |
| -4.0% | 2.8% | 6.6% | -12.3% | -4.5% | -9.0% | 8.6% | -8.7% | 2.7% | 1.0% | -1.6% | -18.6% | -3.8% | |
| 1.5% | 0.7% | 0.2% | 1.1% | 1.4% | 0.1% | 1.9% | 0.5% | 0.3% | 1.2% | 1.5% | 1.6% | 1.1% | |
| -1.5% | -0.7% | 0.0% | -1.1% | -0.9% | -0.1% | -1.9% | -0.5% | -0.3% | -1.2% | -1.5% | -1.6% | -1.1% | |
| 8.6% | 8.7% | 9.6% | 10.4% | 10.5% | 11.3% | 10.5% | 10.1% | 10.1% | 10.8% | 11.3% | 11.6% | 10.9% | |
| 0.0% | -20.2% | -26.4% | -61.6% | -38.6% | -73.3% | -33.2% | -35.0% | -6.7% | -11.0% | -1.5% | -0.9% | -5.1% | |
| -8.3% | -8.7% | -35.1% | -69.1% | -49.2% | -84.6% | -43.6% | -45.1% | -16.7% | -21.8% | -12.8% | -12.5% | -16.0% | |
| 28.7% | 37.8% | 8.3% | -44.1% | -7.7% | -59.8% | 3.6% | -11.5% | 21.3% | 16.5% | 18.9% | 1.4% | 14.8% | |
| 39.5% | 42.5% | 46.3% | 25.5% | 39.9% | 32.0% | 44.1% | 28.4% | 39.2% | 37.2% | 34.2% | 14.6% | 31.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.